The impact of hallucinogens on active sampling and the olfactory bulb
Project Number5F31DC020671-02
Former Number1F31DC020671-01
Contact PI/Project LeaderWELCH, AMANDA COLETTE
Awardee OrganizationUNIVERSITY OF OREGON
Description
Abstract Text
PROJECT SUMMARY
Olfactory hallucinations occur in many disorders, including Parkinson’s disease, epilepsy, schizophrenia, and
migraines, but the neural mechanisms underlying these hallucinations are unknown. Mice have a powerful
olfactory system that is well-studied at the molecular, systems, and behavioral levels. Importantly,
hallucinogens such as LSD, psilocybin, and DOI primarily act on serotonin pathways, which feed heavily into
the mouse olfactory system. The proposed research will determine the behavioral changes in olfactory-driven
behaviors and identify the impact on neural activity in the olfactory bulb.
Mechanistic studies of hallucination in animal models are fundamentally limited, since other animals do not
verbalize what they perceive. However, in lieu of a verbal report, internal states can be inferred from an
animal’s externally observable behavior. Using machine-learning tools, our lab has shown that a mouse’s
behavioral states can be inferred from close analysis of sniffing and movement. In this project, we will
investigate the mouse hallucinogen response using high resolution behavioral analysis and neuronal ensemble
recordings in the olfactory bulb. We hypothesize that hallucinogens will impact olfactory perceptual
reports and strategic sniffing behavior. Further, we hypothesize that the neural activity in the olfactory
bulb will resemble odor-evoked activity in the absence of odor after hallucinogen administration.
To address our hypothesis about perceptual reports, in aim 1 we will train freely-moving mice on a two-
alternative choice task to locate the source of an odor while recording movement and sniffing. After the mice
are trained, we will administer DOI or saline. Our hypothesis predicts that DOI will induce false alarms,
decrease accuracy, and decrease confidence in the presence of an odor stimulus. To address our hypothesis
about neural activity, in aim 2 we will record movement, sniffing, and neural activity in the olfactory bulb during
spontaneous, uninstructed, freely-moving behavior. We will test the prediction that hallucinogen administration
alters the neural dynamics of the olfactory bulb to resemble odor-evoked activity in the absence of an odor
stimulus. Completion of this proposal will provide insight into the behavior and neural circuitry of olfaction and
help inform treatment and policy on the use of hallucinogens to treat various disorders.
Public Health Relevance Statement
PROJECT NARRATIVE
Olfactory hallucinations can be symptomatic of various psychiatric or neurological disorders, including
schizophrenia, Parkinson’s disease, epilepsy, and migraines. This project will determine olfactory-based
behavioral and neural changes induced by hallucinogens in mice. These studies will further our understanding
of sensory processing during perceptual disturbances, a necessary component for the advancement of
diagnosis and treatment of several disorders.
National Institute on Deafness and Other Communication Disorders
CFDA Code
173
DUNS Number
079289626
UEI
Z3FGN9MF92U2
948117312
J2KGU972RXG3
Project Start Date
01-April-2023
Project End Date
31-March-2025
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$47,828
Direct Costs
$47,828
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Deafness and Other Communication Disorders
$47,828
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F31DC020671-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F31DC020671-02
Patents
No Patents information available for 5F31DC020671-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F31DC020671-02
Clinical Studies
No Clinical Studies information available for 5F31DC020671-02
News and More
Related News Releases
No news release information available for 5F31DC020671-02
History
No Historical information available for 5F31DC020671-02
Similar Projects
No Similar Projects information available for 5F31DC020671-02